Varian Medical Systems (VAR) has an average broker rating of 2.06, which is interpreted as a Buy, as rated by 5 equity analysts. Nonetheless, 3 analysts are positive on the stocks future and they recommend a Strong Buy on the stock. Nevertheless, the majority of 1 analysts consider that the stock is a Hold with neither a large upside nor a downside. Ranking by Zacks Investment Research for Coach Inc is 3, which is also a Hold. 1 brokerage firm advices Strong Sell on the share due to lack of confidence about the future of the company.
Varian Medical Systems (VAR) : The consensus price target for Varian Medical Systems (VAR) is $92.8 for the short term with a standard deviation of $6.98. The most optimist securities analyst among the 5 who monitor the stock believes that the stock can reach $102, however, the pessimist price target for the company is $86.
Company shares have received an average consensus rating of Hold for the current week Varian Medical Systems (NYSE:VAR): The stock opened at $95.34 on Thursday but the bulls could not build on the opening and the stock topped out at $95.49 for the day. The stock traded down to $95.05 during the day, due to lack of any buying support eventually closed down at $95.14 with a loss of -0.07% for the day. The stock had closed at $95.21 on the previous day. The total traded volume was 461,742 shares.
In a related news, The Securities and Exchange Commission has divulged that Verhoef Clarence R, officer (SVP, Finance, Corp Controller) of Varian Medical Systems Inc, had unloaded 9,483 shares at an average price of $94.88 in a transaction dated on August 1, 2016. The total value of the transaction was worth $899,747.
Varian Medical Systems Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The Company is a supplier of X-ray imaging components for medical, scientific, and industrial applications and supplies X-ray imaging products for cargo screening and industrial inspection. The Company offers tools for fighting cancer, taking X-ray images and protecting ports and borders. The Companys products include linear accelerators, brachytherapy afterloaders, treatment simulation and verification equipment, accessories, information management, treatment planning and image processing software. The Companys customers include university research and community hospitals, private and governmental institutions, healthcare agencies, doctors offices and cancer care clinics.